Evidence map›Paper›PMID 34183107›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

Low prevalence of diabetes mellitus in TB patients and the community in urban Uganda.

K C Erisa, K O Robsky, P J Kitonsa, A Nalutaaya, D Isooba, O Nakasolya, J Mukiibi, D Dowdy, E A Kendall, A Katamba

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

K C ErisaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
K O RobskyUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
P J KitonsaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
A NalutaayaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
D IsoobaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
O NakasolyaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
J MukiibiUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
D DowdyUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
E A KendallUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Division of Infectious Diseases and Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
A KatambaUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda, Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Makerere University · UGJohns Hopkins University · US

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trialR01HL138728 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI David Wesley Dowdy, Emily A Kendall · 2017 to 2026
$5.4M
Translational modeling of individual- and population-level outcomes of novel tuberculosis drug regimensK08AI127908 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KENDALL, EMILY A · 2017 to 2021
$879k
FIC NIH HHS D43 TW010540NHLBI NIH HHS R01 HL138728NIAID NIH HHS K08 AI127908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusTuberculosisHumansPrevalenceUganda

Identifiers

PMID34183107
PMCPMC8488860
OpenAlexW3176543428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.